tiprankstipranks
Trending News
More News >
ImmuPharma PLC (GB:IMM)
LSE:IMM

ImmuPharma (IMM) Revenue

Compare
27 Followers

ImmuPharma Revenue

ImmuPharma had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, ImmuPharma had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
£0
Employees
5
Market Cap
£30.16M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
-118.35K
Dec 31, 2021
118.35K-8.32K+93.43%
Dec 31, 2020
126.67K48.74K+162.55%
Dec 31, 2019
77.92K-3.36K+95.87%
Dec 31, 2018
81.28K-69.18K+54.02%
Dec 31, 2017
150.46K-14.32K+91.31%
Dec 31, 2016
164.78K